{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:14:09Z","timestamp":1649157249607},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T00:00:00Z","timestamp":1287446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10461-010-9822-9","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T19:07:05Z","timestamp":1287428825000},"page":"389-395","source":"Crossref","is-referenced-by-count":1,"title":["Notes on the Frequency of Routinely Collected and Self-Reported Behavioral Data in HIV Prevention Trials"],"prefix":"10.1007","volume":"15","author":[{"given":"Douglas J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Chin","family":"Lie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lut","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Feldblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folasade","family":"Ogunsola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orikomaba","family":"Obunge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Alary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Mirembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,19]]},"reference":[{"key":"9822_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(07)60950-7","volume":"370","author":"NS Padian","year":"2007","unstructured":"Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007;370:251\u201361.","journal-title":"Lancet"},{"issue":"5","key":"9822_CR2","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.pctr.0020027","volume":"2","author":"L Peterson","year":"2007","unstructured":"Peterson L, Taylor D, Roddy R, et al. Tenofovir Disoproxil Fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled Trial. PLoS Clin Trials. 2007;2(5):e27.","journal-title":"PLoS Clin Trials"},{"key":"9822_CR3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","volume":"360","author":"L Damme Van","year":"2002","unstructured":"Van Damme L, Ramjee G, Alary M, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002;360:971\u20137.","journal-title":"Lancet"},{"key":"9822_CR4","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","volume":"372","author":"S Skoler-Karpoff","year":"2008","unstructured":"Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1977\u201387.","journal-title":"Lancet"},{"issue":"1","key":"9822_CR5","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","volume":"3","author":"PJ Feldblum","year":"2008","unstructured":"Feldblum PJ, Adeiga A, Bakare R, et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One. 2008;3(1):e1474.","journal-title":"PLoS One"},{"key":"9822_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/422603","volume":"190","author":"TA Fleming","year":"2004","unstructured":"Fleming TA, Richardson BA. Some design issues in trials of microbicides for the prevention of HIV infection. J Infect Dis. 2004;190:666\u201374.","journal-title":"J Infect Dis"},{"key":"9822_CR7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.olq.0000237854.25406.ad","volume":"34","author":"EG Raymond","year":"2007","unstructured":"Raymond EG, Taylor D, Cates W Jr, et al. Pregnancy in effectiveness trials of HIV prevention agents. Sex Transm Dis. 2007;34:1035\u20139.","journal-title":"Sex Transm Dis"},{"key":"9822_CR8","doi-asserted-by":"crossref","unstructured":"Tolley EE, Harrison PF, Goetghebeur E, et al. Measuring adherence in phase 2\/3 microbicide trials. AIDS Behav (Published on-line 19 November 2009; doi: 10.1007\/s10461-009-9635-x ).","DOI":"10.1007\/s10461-009-9635-x"},{"key":"9822_CR9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/aje\/kwp219","volume":"170","author":"AM Minnis","year":"2009","unstructured":"Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol. 2009;170:918\u201324.","journal-title":"Am J Epidemiol"},{"key":"9822_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-7622-6-5","volume":"6","author":"BR M\u00e2sse","year":"2008","unstructured":"M\u00e2sse BR, Boily M-C, Dimitrov D, Desai K. Efficacy dilution in randomized placebo-controlled vaginal microbicide trials. Emerg Themes Epidemiol. 2008;6:5.","journal-title":"Emerg Themes Epidemiol"},{"key":"9822_CR11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/OLQ.0b013e3181cd70c2","volume":"37","author":"I McGowan","year":"2010","unstructured":"McGowan I, Taylor D. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies. Sex Transm Dis. 2010;37:361\u20134.","journal-title":"Sex Transm Dis"},{"key":"9822_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1056\/NEJMoa0707957","volume":"359","author":"L Damme Van","year":"2008","unstructured":"Van Damme L, Govinden R, Mirembe FM, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med. 2008;359:463\u201372.","journal-title":"N Engl J Med"},{"issue":"11","key":"9822_CR13","doi-asserted-by":"crossref","first-page":"e3784","DOI":"10.1371\/journal.pone.0003784","volume":"3","author":"V Halpern","year":"2008","unstructured":"Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS ONE. 2008;3(11):e3784.","journal-title":"PLoS ONE"},{"key":"9822_CR14","first-page":"39","volume":"4","author":"D Nagin","year":"1999","unstructured":"Nagin D. Analyzing developmental trajectories: a semiparametric, group based approach. Pschol Methods. 1999;4:39\u2013177.","journal-title":"Pschol Methods"},{"key":"9822_CR15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/QAI.0b013e3181958511","volume":"50","author":"A Straten van der","year":"2009","unstructured":"van der Straten A, Shiboski S, Montogmery ET, et al. Patterns and predictors of adherence to diaphragm use in a phase III trial in Sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr. 2009;50:419\u201326.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"9822_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","volume":"29","author":"B Jones","year":"2001","unstructured":"Jones B, Nagin D, Roeder K. A SAS procedure based on mixed models for estimating developmental trajectories. Sociol Methods Res. 2001;29:374\u201393.","journal-title":"Sociol Methods Res"},{"key":"9822_CR17","volume-title":"SAS\/STAT\u00ae 9.1 User\u2019s Guide","author":"SAS Institute Inc","year":"2004","unstructured":"SAS Institute Inc. SAS\/STAT\u00ae 9.1 User\u2019s Guide. Cary, NC: SAS Institute Inc; 2004."},{"key":"9822_CR18","doi-asserted-by":"crossref","unstructured":"Pool R, Montgomery C, Morar N, et al. Assessing the Accuracy of Adherence and Sexual Behaviour Data in the MDP301 Vaginal Microbicides Trial Using a Mixed Methods and Triangulation Model. PLoS PLoS ONE 2010;5(7): e11632. doi: 10.1371\/journal.pone.0011632 .","DOI":"10.1371\/journal.pone.0011632"},{"key":"9822_CR19","doi-asserted-by":"crossref","unstructured":"Karim QA, Karim SS, Frohlich JA, et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science 2010;329:1168\u201374 (published online 20 July 2010; doi: 10.1126\/science.1193748 ).","DOI":"10.1126\/science.1193748"},{"key":"9822_CR20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-7622-5-8","volume":"5","author":"HA Weiss","year":"2008","unstructured":"Weiss HA, Wasserheit JN, Barnabas RV, Hayes RA, Abu-Raddad LJ. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008;5:8.","journal-title":"Emerg Themes Epidemiol"},{"key":"9822_CR21","volume-title":"Methodological challenges in biomedical HIV prevention trials (Chapter 5)","author":"IOM (Institute of Medicine)","year":"2008","unstructured":"IOM (Institute of Medicine). Methodological challenges in biomedical HIV prevention trials (Chapter 5). Washington, DC: The National Academies Press; 2008."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-010-9822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-010-9822-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-010-9822-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T02:01:41Z","timestamp":1636682501000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-010-9822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,19]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["9822"],"URL":"https:\/\/doi.org\/10.1007\/s10461-010-9822-9","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,19]]}}}